Books　　Original Articles　　Case Reports　　Reviews 1. Itoh H, Naganuma S, Uchiyama S, Nagaike K, Tanaka H, Kataoka H. Activation of hepatocyte growth factor / scatter factor is required in colorectal carcinoma and injured intestinal mucosa. Recent Research Developments in Biophysics and Biochemistry, pp1-16, Research Signpost, Kerala, India, 2004. 2. Kataoka H, Akiyama Y, Seguchi T, Naganuma S, Itoh, H. Immunohistochemical analysis of hepatocyte growth factor activator and its inhibitor HAI-1: Implication for reguneration of injured tissue and tumor progression. Recent Research and Development of Histopathology pp. 67-76, Research Signpost, Kerala, India, 2002. 3. Katoh M, Itoh H, Kishi T, Ishii H, Hattori Y, Sakamoto H, Yoshida T, Sugimura T, Terada M. Implication of the K-sam/FGFR2 gene in the development and progression of gastric cancer. In 1st International Gastric Cancer Congress (Nishi, M., Sugano, H., and Takahashi, T., eds.) pp. 763-766, Monduzzi Editore S. p. A., Bologna, Italy, 1995. ▲Page top 1. Tsuchiyama K, Ito H, Taga M, Naganuma S, Oshinoya Y, Nagano K, Yokoyama O, Itoh H. (corresponding author) Expression of microRNAs associated with Gleason grading system in prostate cancer. Prostate 73, 827-834, 2013. 2. Takeuchi H, Hosoda T, Kitai R, Kodera T, Arishima H, Tsunetoshi K, Neishi H, Yamauchi T, Sato K, Imamura Y, Itoh H, Kubota T, Kikuta K. Glioblastoma with oligodendroglial components: glioblastoma or anaplastic oligodendroglial tumors. Brain Tumor Pathol, 29, 154-159, 2012. 3. Takeuchi H, Hosoda T, Kitai R, Kodera T, Arishima H, Tsunetoshi K, Neishi H, Yamauchi T, Sato K, Imamura Y, Itoh H, Kubota T, Kikuta K. Clinicopathological features in the recurrence of oligodendroglioma and diffuse astrocytoma. Brain Tumor Pathol, 29, 140-147, 2012. 4. Naganuma S, Whelan KA, Natsuizaka M, Kagawa S, Kinugasa H, Chang S, Subramanian H, Rhoades B, Ohashi S, Itoh H, Herlyan M, Diehl JA, Gimotty PA, Klein-Szanto AJ, Nakagawa H. Notch receptor inhibition reveals the importance of cyclin D1 and Wnt signaling in invasive esophageal squamous cell carcinoma. Am J Cancer Res, 2, 459-475, 2012. 5. Ikeda T, Anisuzzaman AS, Yoshiki H, Sasaki M, Koshiji T, Uwada J, Nishimune A, Itoh H, Muramatsu I. Regional quantification of muscarinic acetylcholine receptors and -adrenoceptors in human airways. Br J Pharmacol, 166, 1804-1814, 2012. 6. Susuki D, Kimura S, Naganuma S, Tsuchiyama K, Tanaka T, Kitamura N, Fujieda S, Itoh H. (corresponding author) Regulation of microRNA expression by hepatocyte growth factor in human head and neck squamous cell carcinoma. Cancer Sci. 102, 2164-2171, 2011. 7. Ohashi S, Natsuizaka M, Naganuma S, Kagawa S, Kimura S, Itoh H, Kaiman RA, Nakagawa M, Darling DS, Basu D, Gimotty PA, Klein-Szanto AJ, Diehl JA, Herlyn M, Nakagawa H. A NOTCH3-mediated squamous cell differentiation program limits expansion of EMT-competent cells that express the ZEB transcription factors. Cancer Res. 71, 6836-6847, 2011. 8. Kimura S, Naganuma S, Susuki D, Hirono Y, Yamaguchi A, Fujieda S, Sano K, Itoh H. (corresponding author) Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. Oncol. Rep. 23, 1625-1633, 2010. 9. Katayama K, Yamaguchi A, Murakami M, Koneri K, Nagano H, Honda K, Hirono Y, Goi T, Iida A, Itoh H. Chemo-hyperthermic peritoneal perfusion(CHPP)for appendiceal pseudomyxoma peritonei. Int. J. Clin. Oncol. 14, 120-124, 2009. 10. Komaki W, Fukushima T, Tanaka H, Itoh H, Chosa E, Kataoka H. Expression of hepatocyte growth factor activator inhibitor type 1 on the epithelial cell surface is regulated by hypoxic and oxidative stresses. Virchows Arch. 453, 347-357, 2008. 11. Amano M, Kurokawa M, Ogata K, Itoh H, Kataoka H, Setoyama M. New entity, definition and diagnostic criteria of cutaneous adult T-cell leukemia/lymphoma: human T-lymphotropic virus type 1 proviral DNA load can distinguish between cutaneous and smoldering types. J. Dermatol. 35, 270-275, 2008. 12. Kinoshita H, Miyoshi N, Miyauchi K, Ogawa T, Kitagawa T, Itoh H, Sano K. Phosphate mapping of sialoliths with Raman microspectroscopy. J. Raman Spectrosc. 39, 349-353, 2008. 13. Yayama T, Uchida K, Kobayashi S, Kokubo Y, Sato R, Nakajima H, Takamura T, Bangirana A, Itoh H, Baba H. Thoracic ossification of the human ligamentum flavum: histopathological and immunohistochemical findings around the ossified lesion. J. Neurosurg. Spine 7, 184-193, 2007. 14. Sato R, Uchida K, Kobayashi S, Yayama T, Kokubo Y, Nakajima H, Takamura T, Bangirana A, Itoh H, Baba H. Ossification of the posterior longitudinal ligament of the cervical spine: histopathological findings around the calcification and ossification front. J. Neurosurg. Spine 7, 174-183, 2007. 15. Uchiyama S, Itoh H, Naganuma S, Nagaike K, Fukushima T, Tanaka H, Hamasuna R, Chijiiwa K, Kataoka H. Enhanced expression of hepatocyte growth factor activator inhibitor type 2-related small peptide (H2RSP) at the invasive front of colon cancers. Gut 56, 215-226, 2007. 16. Naganuma S, Itoh H, Uchiyama S, Nagaike K, Tanaka H, Akiyama Y, Chijiiwa K, Kataoka H. Nuclear translocation of H2RSP is impaired in regenerating intestinal epithelial cells of murine colitis model. Virchows Arch, 448, 354-360, 2006. 17. Uchinokura S, Miyata S, Fukushima T, Itoh H, Nakano S, Wakisaka S, Kataoka H. Role of hepatocyte growth factor activator (HGF activator) in invasive growth of human glioblastoma cells in vivo. Int. J. Cancer, 118, 583-592, 2006. 18. Tanaka H, Nagaike K, Takeda N, Itoh H, Kohama K, Fukushima T, Miyata S, Uchinokura S, Shimomura T, Miyazawa K, Kitamura N, Yamada G, Kataoka H. Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantonic placenta. Mol. Cell. Biol. 25, 5687-5698, 2005. 19. Miyata S, Uchinokura S, Fukushima T, Hamasuna R, Itoh H, Akiyama Y, Nakano S, Wakisaka S, Kataoka H. Diverse roles of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in the growth of glioblastoma cells in vivo. Cancer lett. 227, 83-93, 2005. 20. Nuki Y, Uchinokura S, Miyata S, Fukushima T, Hamasuna R, Nakono S, Wakisaka S, Akiyama Y, Itoh H, Kataoka H. Establishment and characterization of a new human glioblastoma cells line, NYGM. Hum. Cell 17, 145-150, 2004. 21. Itoh H, Naganuma S, Takeda N, Miyata S, Uchinokura S, Fukushima T, Uchiyama S, Tanaka H, Nagaike K, Shimomura T, Miyazawa K, Yamada G, Kitamura N, Koono M, Kataoka H. Regeneration of injured intestinal mucosa is impaired in hepatocyte growth factor activator-deficient mice. Gastroenterology 127, 1423-1435, 2004. 22. Nagaike K, Kohama K, Uchiyama S, Tanaka H, Chijiiwa K, Itoh H, Kataoka, H. Paradoxically enhanced immunoreactivity of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in cancer cells at the invasion front. Cancer Sci. 95, 728-735, 2004. 23. Yamauchi M, Kataoka H, Itoh H, Seguchi T, Hasui Y, Osada Y. Hepatocyte growth factor activator inhibitor type 1 (HAI-1) and type 2 (HAI-2) are expressed by tubular epithelium in kidney and downregulated in renal cell carcinoma. J. Urol. 171, 890-896, 2004. 24. Naganuma S, Itoh H, Uchiyama S, Tanaka H, Nagaike K, Miyata S, Uchinokura S, Nuki S, Akiyama Y, Chijiiwa K, Kataoka H. Characterization of transcripts generated from mouse hepatocyte growth factor activator inhibitor type 2 (HAI-2) and HAI-2-related small peptide (H2RSP) genes. Biochem. Biophys. Res. Commun. 302, 345-353, 2003. 25. Suzuki M, Kobayashi H, Tanaka Y, Hirashima Y, Kanayama N, Takei Y, Saga Y, Suzuki M, Itoh H, Terao T. Bikunin target genes in ovarian cancer cells identified by microarray analysis. J. Biol. Chem. 278, 14640-14646, 2003. 26. Suzuki M, Kobayashi H, Tanaka Y, Hirashima Y, Kanayama N, Takei Y, Saga Y, Suzuki M, Itoh H, Terao T. Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cell line by overexpression of bikunin. Int. J. Cancer 104, 289-302, 2003. 27. Sugiki M, Omura S, Yoshida E, Itoh H, Kataoka H, Maruyama M. Downregulation of urokinase-type and tissue-type plasminogen activators in a rabbit model of renal ischemia/reperfusion. J. Biochem. 132, 501-508, 2002. 28. Yamauchi M, Itoh H, Naganuma S, Koono M, Hasui Y, Osada Y, Kataoka H. Expression of hepatocyte growth factor activator inhibitor type 2 (HAI-2) in human testis: Identification of a distinct transcription start site for the HAI-2 gene in testis. Biol. Chem. 383, 1953-1957, 2002. 29. Kataoka H, Itoh H, Nuki Y, Hamasuna R, Naganuma S, Kitamura N, Shimomura T. Mouse hepatocyte growth factor (HGF) activator inhibitor type 2 lacking the first Kunitz domain potently inhibits the HGF activator. Biochem. Biophys. Res. Commun. 290, 1096-1100, 2002. 30. Itoh H, Kataoka H, Yamauchi M, Naganuma S, Akiyama Y, Nuki Y, Shimomura T, Miyazawa K, Kitamura N, Koono M. Identification of hepatocyte growth factor activator inhibitor type 2 (HAI-2) related small peptide (H2RSP): its nuclear localization and generation of chimeric mRNA transcribed from both HAI-2 and H2RSP genes. Biochem. Biophys. Res. Commun. 288, 390-399, 2001. 31. Hamasuna R, Kataoka H, Meng JY, Itoh H, Moriyama T, Wakisaka S, Koono M. Reduced expression of hepatocyte growth factor activator inhibitor type-2/placental bikunin (HAI-2/PB) in human glioblastomas: Implication for anti-invasive role of HAI-2/PB in glioblastoma cells. Int. J. Cancer 93, 339-345, 2001 32. Itoh H, Kataoka H, Meng JY, Hamasuna R, Kitamura N, Koono M. Mouse hepatocyte growth factor activator inhibitor type 1 (HAI-1) and type 2 (HAI-2)/placental bikunin genes and their promoters. Biochim. Biophys. Acta 1519, 92-95, 2001. 33. Meng JY, Kataoka H, Itoh H, Koono M. Amyloid  protein precursor is involved in the growth of human colon carcinoma cell in vitro and in vivo. Int. J. Cancer 92, 31-39, 2001. 34. Kataoka H, Meng JY, Itoh H, Hamasuna R, Shimomura T, Suganuma T, Koono M. Localization of hepatocyte growth factor activator inhibitor type 1 in Langhans’ cells of human placenta. Histochem. Cell Biol. 114, 469-475, 2000. 35. Kataoka H, Shimomura T, Kawaguchi T, Hamasuna R, Itoh H, Miyazawa K, Kitamura N, Koono M. Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in pericellular microenvironment. J. Biol. Chem. 275, 40453-40462, 2000. 36. Kataoka H, Hamasuna R, Itoh H, Kitamura N, Koono M. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma. Cancer Res. 60, 6148-6159, 2000. 37. Kinoshita K, Taupin DR, Itoh H, Podolsky DK. Distinct pathways of cell migration and antiapoptotic response to epithelial injury: structure-function analysis of human intestinal trefoil factor. Mol. Cell. Biol. 20, 4680-4690, 2000. 38. Itoh H, Yamauchi M, Kataoka H, Hamasuna R, Kitamura N, Koono M. Genomic structure and chromosomal localization of the human hepatocyte growth factor activator inhibitor type 1 and 2 genes. Eur. J. Biochem. 267, 3351-3359, 2000. 39. Itoh H, Hamasuna R, Kataoka H, Yamauchi M, Miyazawa K, Kitamura N, Koono M. Mouse hepatocyte growth factor activator gene: its expression not only in the liver but also in the gastrointestinal tract. Biochim. Biophys. Acta 1491, 295-302, 2000. 40. Tomita M, Kobayashi T, Itoh H, Onitsuka T, Nawa Y. Goblet cell hyperplasia in the airway of Nippostrongylus brasiliensis-infected rats. Respiration 67, 565-569, 2000. 41. Itoh H, Kataoka H, Tomita M, Hamasuna R, Nawa Y, Kitamura N, Koono M. Up-regulation of hepatocyte growth factor activator inhibitor type-1 but not type-2 along with regeneration of intestinal mucosa. Am. J. Physiol.Gastrointest. Liver Physiol. 278, G635-G643, 2000. 42. Kataoka H, Itoh H, Uchino H, Hamasuna R, Kitamura N, Nabeshima K, Koono M. Conserved expression of hepatocyte growth factor activator inhibitor type 2 / placental bikunin in humna colorectal carcinomas. Cancer Lett. 148, 127-134, 2000. 43. Uchino H, Kataoka H, Itoh H, Hamasuna R, Koono M. Overexpression of intestinal trefoil factor in human colon carcinoma cells reduces cellular growth in vivo and in vitro. Gastroenterology 118, 60-69, 2000. 44. Itoh H, Beck PL, Inoue N, Xavier R, Podolsky DK. A paradoxical reduction in susceptibility to colonic injury upon targeted transgenic ablation of goblet cells. J. Clin. Invest. 104, 1539-1547, 1999. 45. Tomita M, Itoh H, Kobayashi T, Onitsuka T, Nawa Y. Expression of mast cell proteases in rat lung during helminth infection: Mast cells express both rat mast cell protease II and tryptase in helminth infected lung. Int. Arch Allergy Immunol. 120, 303-309, 1999. 46. Itoh H, Inoue N, Podolsky DK. Goblet cell-specific transcription of mouse intestinal trefoil factor gene results from collaboration of complex series of positive and negative regulatory elements. Biochem. J. 341, 461-472, 1999. 47. Hamasuna R, Kataoka H, Moriyama T, Itoh H, Seiki M, Koono M. Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor / scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP-2 expression and activation accompanying with up-regulation of membrane type-1 MMP. Int. J. Cancer 82, 274-281, 1999. 48. Ide H, Itoh H, Yoshida E, Kobayashi T, Tomita M, Maruyama H, Osada Y, Nakahata, T. Nawa Y. Immunohistochemical demonstration of inter--trypsin inhibitor light chain (bikunin) in human mast cells. Cell Tissue Res. 297, 149-154, 1999. 49. Kataoka H, Suganuma T, Shimomura T, Itoh H, Denda K, Kitamura N, Nabeshima K, Koono M. Distribution of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in human tissues: cellular surface localization of HAI-1 in simple columnar epithelium and its modulated expression in injured and regenerative tissues. J. Histochem. Cytochem. 47, 673-682, 1999. 50. Itoh H, Kataoka H, Hamasuna R, Kitamura N, Koono M. Hepatocyte growth factor activator inhibitor type 2 lacking the first Kunitz-type serine proteinase inhibitor domain is a predominant product in mouse but not in human. Biochem. Biophys. Res. Commun. 255, 740-748, 1999. 51. Nabeshima K, Shimao Y, Inoue T, Itoh H, Kataoka H, Koono M. Hepatocyte growth factor / scatter factor induces not only scattering but also cohort migration of human colorectal-adenocarcinoma cells. Int. J. Cancer 78, 750-759, 1998. 52. Kataoka H, Uchino H, Denda K, Kitamura N, Itoh H, Tsubouchi K, Nabeshima K, Koono M. Evaluation of hepatocyte growth factor activator inhibitor expression in normal and malignant colonic mucosa. Cancer Lett. 128, 219-227, 1998. 53. Uchino H, Kataoka H, Itoh H, Koono M. Expression of intestinal trefoil factor mRNA is downregulated during progression of colorectal carcinomas. J. Clin. Pathol. 50, 932-934, 1997. 54. Itoh H, Tomita M, Uchino H, Kobayashi T, Kataoka H, Sekiya R, Nawa Y. cDNA cloning of rat pS2 peptide and expression of trefoil peptides in acetic acid-induced colitis. Biochem. J. 318, 939-944, 1996. 55. Hattori Y, Itoh H, Uchino S, Hosokawa K, Ochiai A, Ino Y, Ishii H, Sakamoto H, Yamaguchi N, Yanagihara K, Hirohashi S, Sugimura T, Terada M. Immunohistochemical detection of K-sam protein in stomach cancer. Clin. Cancer Res. 2, 1373-1381, 1996. 56. Itoh H, Tomita M, Kobayashi T, Uchino H, Maruyama H, Nawa Y. Expression of inter--trypsin inhibitor light chain (bikunin) in human pancreas. J. Biochem. 120, 271-275, 1996. 57. Itoh H, Murakumo Y, Tomita M, Ide H, Kobayashi T, Maruyama H, Horii Y, Nawa Y. Cloning of the cDNAs for mast cell chymases from the jejunum of Mongolian gerbils, Meriones unguiculatus, and their sequence similarities with chymases expressed in the connective tissue mast cells of mice and rats. Biochem. J. 314, 923-929, 1996. 58. Ide H, Itoh H, Tomita M, Murakumo Y, Kobayashi T, Maruyama H, Osada Y, Nawa Y. Cloning of the cDNA encoding a novel rat mast cell protease, rMCP-3, and its expression in comparison with other rat mast cell proteases. Biochem. J. 311, 675-680, 1995. 59. Tomita M, Itoh H, Ishikawa N, Higa A, Ide H, Maruyama H, Koga Y, Nawa Y. Molecular cloning of mouse intestinal trefoil factor and its expression during goblet cell changes. Biochem. J. 311, 293-297, 1995. 60. Ide H, Itoh H, Tomita M, Murakumo Y, Kobayashi T, Maruyama H, Osada Y, Nawa Y. cDNA sequencing and expression of rat mast cell tryptase. J. Biochem. 118, 210-215, 1995. 61. Murakumo Y, Ide H, Itoh H, Tomita M, Kobayashi T, Maruyama H, Horii Y, Nawa Y. Cloning of the cDNA encoding mast cell tryptase of Mongolian gerbil, Meriones unguiculatus, and its preferential expression in the intestinal mucosa. Biochem. J. 309, 921-926, 1995. 62. Ide H, Itoh H, Nawa Y. Sequencing of cDNA encoding 1-microglobulin/bikunin of Mongolian gerbil and Syrian golden hamster in comparison with man and other species. Biochim. Biophys. Acta 1209, 286-292, 1994. 63. Shi BB, Ishikawa N, Itoh H, Ide H, Tsuchiya K, Horii Y, Uchiyama F, Nawa Y. Goblet cell mucin of four genera of the subfamily cricetinae with reference to the protective activity against Strongyloides venezuelensis. Parasite Immunol. 16, 553-559, 1994. 64. Itoh H, Ide H, Kataoka H, Tomita M, Yoshihara H, Nawa Y. cDNA sequencing of mouse 1-microglobulin/inter--trypsin inhibitor light chain and its expression in acute inflammation. J. Biochem. 116, 767-772, 1994. 65. Shi BB, Ishikawa N, Itoh H, Khan AI, Tsuchiya K, Horii Y, Nawa Y. Goblet cell hyperplasia induced by Storongyloides venezuelensis-infection in syrian golden hamster, Mesocricetus auratus. Int. J. Parasitol. 25, 399-402, 1994. 66. Itoh,H, Hattori Y, Sakamoto H, Ishii H, Kishi T, Sasaki H, Yoshida T, Koono M, Sugimura T, Terada M. Preferential alternative splicing in cancer generates a K-sam mRNA with higher transforming activity. Cancer Res. 54, 3237-3241, 1994. 67. Ishii H, Hattori Y, Itoh H, Kishi T, Yoshida T, Sakamoto H, Oh H, Yoshida S, Sugimura T, Terada M. Preferential expression of the third immunoglobulin-like domain of K-sam product provides keratinocyte growth factor-dependent growth in carcinoma cell lines. Cancer Res. 54, 518-522, 1994. 68. Itoh H, Ide H, Ishikawa N, Nawa Y. Mast cell protease inhibitor, trypstatin, is a fragment of inter--trypsin inhibitor light chain. J. Biol. Chem. 269, 3818-3822, 1994. 69. Kataoka H, Itoh H, Seguchi K, Koono M. Establishment and characterization of a human lung adenocarcinoma cell line (LC-2/ad) producing alpha-1-antitrypsin in vitro. Acta Pathol. Japon.(Pathol. Int.) 43, 566-573, 1993. 70. Itoh H, Kataoka H, Koita H, Nabeshima K, Inoue T, Kangawa K, Koono M. Establishment of a new human cancer cell line secreting protease nexin-II/amyloid  protein precursor derived from squamous-cell carcinoma of lung. Int. J. Cancer 49, 436-443, 1991. 71. Karashima S, Kataoka H, Itoh H, Maruyama R, Koono M. Prognostic significance of alpha-1-antitrypsin in early stage of colorectal carcinomas. Int. J. Cancer 45, 244-250, 1990. ▲Page top 1. Miyazaki T, Uchida K, Yayama T, Nakajima H, Honjoh K, Itoh H, Oda Y, Baba H. Chondroblastoma of the distal femur resected through a small fenestra via computed tomography navigation and endoscopy: a case report. J Med Case Rep, 7: 164-168, 2013. 2. Kiyohara T, Takata M, Itoh H, Kawami K, Ido H, Ishida H, Kumakiri M. Malignant melanoma arising from an NRAS-mutated medium-sized congenital melanocytic nevus. J Dermatol, 39, 1034-1035, 2012. 3. Uchida K, Miyazaki T, Nakajima H, Negoro K, Sugita D, Watanabe S, Yoshimura M, Itoh H, Baba H. Cutaneous squamous cell carcinoma (SCC) arising in stump of amputated finger in a patient with resected glossal SCC. BMC Res Notes, 5, 595-597, 2012. 4. Kiyohara T, Takata M, Itoh H, Kawami K, Yasuta M, Hayakawa K, Kumakiri M. HRAS-mutated Spitz nevus on the cheek in a middle-aged man. Acta Derm. Venereol, 92, 326-327, 2012. 5. Naganuma S, Honda K, Noriki S, Kimura S, Murakami M, Koneri K, Katayama K, Yamaguchi A, Itoh H. (corresponding author) Ruptured mucinous cystic neoplasm with an associated invasive carcinoma of pancreas head in a pregnant woman: report of a case and review of literature. Pathol. Int. 61, 28-33, 2011. 6. Takahashi N, Kimura H, Kitai R, Sato M, Yoneda M, Yamamoto C, Mikami D, Kuriyama M, Kubota T, Itoh H, Yoshida H. Acute on chronic subdural hematoma as a rare complication in a microscopic polyangiitis patient receiving antithrombotic treatment. Clin. Nephrol. 72, 211-215, 2009 7. Seguchi T, Kyoraku Y, Saita K, Ihi T, Nagai M, Akiyama Y, Itoh H, Kataoka H. Human T-cell lymphotropic virus type I (HTLV-1) associated myelopathy and Sjogren's syndrome representing pulmonary nodular amyloidosis and multiple bullae: Report of an autopsy case. Virchows Arch. 448, 874-876, 2006. 8. Miyata S, Sugimoto T, Kodama T, Akiyama Y, Nakano S, Wakisaka S, Itoh H, Kataoka H. Adenoid glioblastoma arising in a patient with neurofibromatosis type-1 (NF1): Report of a case. Pathol. Int. 55, 348-352, 2005. 9. Itoh H, Wada T, Michikata K, Sato Y, Seguchi T, Akiyama Y, Kataoka H. Ovarian teratoma showing a predominant hemangiomatous element with stromal luteinization: report of a case and review of the literature. Pathol. Int. 54, 279-283, 2004. 10. Seguchi T, Akiyama Y, Itoh H, Tanaka H, Naganuma S, Nagaike K, Uchiyama S, Kataoka H. Multiple hepatic peribiliary cysts with cirrhosis: Report of three cases. J. Gastroentrol. 39, 384-390, 2004. 11. Itoh H, Ishihara A, Koita H, Hatakeyama K, Seguchi T, Akiyama Y, Kataoka H. Ovarian pregnancy: Report of 4 cases and review of the literature Pathol. Int. 53, 806-809, 2003. 12. Itoh H, Hinoura Y, Aratake Y, Sato S, Ohno A, Miyaguni H, Kataoka H, Koono M. Cytology of primary cutaneous Langerhans cell histiocytosis showing malignant phenotype: A case report. Acta Cytol. 46, 731-734, 2002. 13. Itoh H, Yanagi M, Setoyama T, Shirao K, Yanagi S, Kataoka H, Shimotakahara T, Koono M. Solitary fibroleiomyomatous hamartoma of the lung in a man without pre-existing smooth muscle tumor: Report of a case. Pathol. Int. 51, 661-665, 2001. 14. Itoh H, Miyaguni H, Kataoka H, Akiyama Y, Tateyama S, Marutsuka K, Asada Y, Ogata K, Koono M. Primary cutaneous Langerhans cell histiocytosis showing malignant phenotype in an elderly woman; report of a fatal case. J. Cutan. Pathol. 28, 371-378, 2001. 15. Itoh H, Chuganji Y, Kodama Y, Seguchi T, Kataoka H, Ikenoue T, Koono M. Pena-Shokeir type I syndrome with thymic and systemic lymphoid hyperplasia: report of an autopsy case. Hum. Pathol. 31, 1321-1324, 2000. 16. Kataoka H, Akiyama Y, Kubo S, Itoh H, Tajima N, Koono M. Solitary fibrous tumor of the spinal nerve rootlet: case report and literature survey. Pathol. Int. 49, 826-830, 1999. 17. Kodama S, Itoh H, Ide H, Kataoka H, Takehara T, Nagano M, Hamasuna R, Koono M, Osada Y. Carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) producing adenocarcinoma of the prostate: report of autopsy case. Urol. Int. 63, 193-197, 1999. 18. Itoh H, Kuwata G, Tateyama S, Yamashita K, Inoue T, Kataoka H, Ido K, Ogata K, Takasaki M, Inoue S, Tsubouchi H, Koono M. Aeromonas sobria infection with severe soft tissue damage and segmental necrotizing gastroenteritis in a patient with alcoholic liver cirrhosis: report of an autopsy case. Pathol. Int. 49, 541-546, 1999. 19. Itoh H, Shitamura T, Kataoka H, Ide H, Akiyama Y, Hamasuna R, Hasui Y, Osada Y, Koono, M. Retroperitonel bronchogenic cyst: report of a case and review of the literature. Pathol. Int. 49, 152-155, 1999. 20. Maruyama H, Kobayashi T, Tomita M, Itoh H, Hiramoto Y, Endo Y, Takada S, Kosakamoto H, Imakada K, Yoshimata T, Nakamura I, Nawa Y. Immunoserologically diagnosed Toxocariasis with bilateral pleural effusion. Jpn. J. Parasitol. (Parasitol. Int.) 44, 248-253, 1995. 21. Hidaka K, Ueda M, Maruyama H, Kobayashi T, Ishikawa N, Tomita M, Ide H, Itoh H, Nawa Y. Immunoserologically diagnosed Strongyloides-pneumonitis with pleural effusion and eosinophilia. Jpn. J. Parasitol. (Parasitol. Int.) 44, 176-180, 1995. 22. Seguchi K, Matsuno M, Kataoka H, Kobayashi T, Maruyama H, Itoh H, Koono M, Nawa Y. A case report of colonic ileus due to eosinophilic nodular lesions caused by Gnathostoma doloresi infection. Am. J. Trop. Med. Hyg. 53, 263-266, 1995. 23. Shimao Y, Koono M, Ochiai A, Fujito A, Ide H, Kobayashi T, Maruyama H, Itoh H, Nawa Y. A case report of intraperitoneal granuloma due to occult infection with Paragonimus sp.. Jpn. J. Parasitol. (Parasitol. Int.) 43, 315-317, 1994. ▲Page top 1. Kataoka H, Tanaka H, Nagaike K, Uchiyama S, Itoh H. Roles of cancer cell-stroma interaction in invasive growth of cancer cells. Hum. Cell 16, 1-14, 2003. 2. Kataoka H, Miyata S, Uchinokura S, Itoh H. Roles of hepatocyte growth factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF/scatter factor. Cancer Metast. Rev. 22, 223-236,2003. 3. Itoh H. Kataoka H. (corresponding author) Roles of hepatocyte growth factor activator (HGFA) and its inhibitor HAI-1 in the regeneration of injured gastrointestinal mucosa. J. Gastroenterol. 37 (Supple 14), 15-21, 2002. 4. Kataoka H, Itoh H, Koono M. Emerging multifunctional aspects of cellular serine proteinase inhibitors in tumor progression and tissue regeneration. Pathol. Int. 52, 89-102, 2002. 5. Kataoka H, Itoh H, Shimomura T, Nuki Y, Naganuma S, Miyazawa K. Regulation of hepatocyte growth factor (HGF) activation on ccell surface: Insight into an emerging class of cell surface protease inhibitors. Int. Arch. Biosci. 1, 1036-1042, 2001. 6. Kataoka H, Itoh H, Hamasuna R, Meng JY, Koono M. Pericellular activation of hepatocyte growth factor/scatter factor (HGF/SF) in colorectal carcinomas: Roles of HGF activator (HGFA) and HGFA inhibitor type 1 (HAI-1). Hum. Cell 14, 83-93, 2001. 7. Uchino H, Kataoka H, Itoh H, Sekiya R, Onitsuka T, Koono M. Roles of intestinal trefoil factor (ITF) in human colorectal cancer: ITF suppresses the growth of colorectal carcinoma cells. Hum. Cell 12, 181-188, 1999. 8. Ohmori J, Tomita M, Itoh H, Nawa Y, Ge Y B, Yang DH, Tsuyama S, Murata F. Eosinophil peroxidase deficiency in human and mice. Acta Histochem. Cytochem. 30, 231-236, 1997. 9. Nawa Y, Ishikawa N, Tsuchiya K, Horii Y, Abe T, Khan AI, Shi BB, Itoh H, Ide H, Uchiyama F. Selective effector mechanisms for the expulsion of intestinal helminths. Parasite Immunol. 16, 333-338, 1994. ▲Page top
	Reserch Publications Protocols and others Staff Link Access HOME Department of Pathology Yamaguchi University School of Medicine. Tel +81-836-22-2221 Fax +81-836-22-2223 E-mail pathol2@yamaguchi-u.ac.jp copyright (c) Department of Molecular Pathology Yamaguchi University Graduate School of Medicine all rights reserved.